Autres langues Sunshine Biopharma, Inc.

Actions

SBFM

US8677816014

Cours en clôture Nasdaq Autres places de cotation 00:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
0,95 ^USD	+17,66%		-34,03%	-96,50%

12/04	Les actions de Sunshine Biopharma chutent après l'annonce du regroupement d'actions	MT
28/03	Sunshine Biopharma, Inc. déclare ses résultats pour l'année complète terminée le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg, a Biosimilar of Neulasta	22/04
Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product	19/04
Top Premarket Decliners	19/04
Sunshine Biopharma Announces Reverse Stock Split	15/04
Sunshine Biopharma Shares Slump After Reverse Stock Split Announcement	12/04
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	28/03
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Sunshine Biopharma, Inc. announced that it has received $5 million in funding	28/03
Thinking about buying stock in Mediwound, AeroVironment, Airship AI, Lyell Immunopharma, or Sunshine Biopharma?	06/03
Sunshine Biopharma, Inc. announced that it expects to receive $0.01 million in funding	04/03
Sunshine Biopharma, Inc. Announces Executive Changes	30/01
Sunshine Biopharma Moves Principal Office to New York City	04/12
Sunshine Biopharma, Inc. Announces Move Its Headquarters to New York City	04/12
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	13/11
Sunshine Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Jewish General Hospital Announces Termination of the Research Agreement with Sunshine Biopharma, Inc	02/11
Sunshine Biopharma Gets Extension to Comply With Nasdaq Minimum Bid Price Rule	22/09/23
Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%	11/08/23
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	10/08/23
Sunshine Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sunshine Biopharma, Inc.

Actions

SBFM

US8677816014

Autres langues

Filtres